BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17187696)

  • 21. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
    Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
    J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilizing the tumor-node-metastasis staging for prostate cancer: the sixth edition, 2002.
    Chang SS; Amin MB
    CA Cancer J Clin; 2008; 58(1):54-9. PubMed ID: 18096866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. History and international developments in cancer staging.
    Gospodarowicz M; Benedet L; Hutter RV; Fleming I; Henson DE; Sobin LH
    Cancer Prev Control; 1998 Dec; 2(6):262-8. PubMed ID: 10470455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The electromagnetic detection of prostatic cancer: evaluation of diagnostic accuracy.
    Tubaro A; De Nunzio C; Trucchi A; Stoppacciaro A; Miano L
    Urology; 2008 Aug; 72(2):340-4. PubMed ID: 18336888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
    Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M
    Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of care indicators for prostate cancer: progress toward consensus.
    Miller DC; Saigal CS
    Urol Oncol; 2009; 27(4):427-34. PubMed ID: 19573774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An audit of colon cancer data on the New Zealand Cancer Registry.
    Cunningham R; Sarfati D; Hill S; Kenwright D
    N Z Med J; 2008 Aug; 121(1279):46-56. PubMed ID: 18709047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring indicators of health care quality by means of a hospital register of tumours.
    Redondo M; Rivas-Ruiz F; Guzman-Soler MC; Labajos C
    J Eval Clin Pract; 2008 Dec; 14(6):1026-30. PubMed ID: 19019095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point-of-care outcome assessment in the cancer clinic: audit of data quality.
    Wong K; Huang SH; O'Sullivan B; Lockwood G; Dale D; Michaelson T; Waldron J; Bayley A; Cummings B; Dawson LA; Kim J; Liu G; Ringash J
    Radiother Oncol; 2010 Jun; 95(3):339-43. PubMed ID: 20362349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of treatment guidelines and implementation of a quality assurance program on quality of care in endometrial cancer.
    du Bois A; Strutas D; Buhrmann C; Traut A; Ewald-Riegler N; Kommoss S; Gomez R; Harter P
    Onkologie; 2009 Sep; 32(8-9):493-8. PubMed ID: 19745593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The quality audit in a blood transfusion center].
    Hergon E
    Transfus Clin Biol; 1998 Dec; 5(6):422-30. PubMed ID: 9894334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
    Tonita JM; Skarsgard D; Muhajarine N
    Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
    Scales CD; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL; Freedland SJ;
    J Urol; 2007 Oct; 178(4 Pt 1):1249-52. PubMed ID: 17698131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data from a national lung cancer registry contributes to improve outcome and quality of surgery: Danish results.
    Jakobsen E; Palshof T; Osterlind K; Pilegaard H
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):348-52; discussion 352. PubMed ID: 19070503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Observational survey on variations of prostate cancer incidence by stage in the Nord-Pas-de-Calais region between 1998 and 2004].
    Flamand V; Zini L; Salleron J; Fantoni JC; Biserte J; Villers A
    Prog Urol; 2008 Jan; 18(1):53-9. PubMed ID: 18342157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staging saturation biopsy in patients with prostate cancer on active surveillance protocol.
    Abouassaly R; Lane BR; Jones JS
    Urology; 2008 Apr; 71(4):573-7. PubMed ID: 18387385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in clinical TNM staging documentation within a prostate cancer quality improvement collaborative.
    Filson CP; Boer B; Curry J; Linsell S; Ye Z; Montie JE; Miller DC
    Urology; 2014 Apr; 83(4):781-6. PubMed ID: 24680448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.